SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 8/09/16 American Renal Assocs Holdin… Inc 10-Q 6/30/16 58:5.7M |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 779K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 25K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 21K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 20K 12: R1 Document and Entity Information HTML 38K 13: R2 Consolidated Balance Sheets HTML 109K 14: R3 Consolidated Balance Sheets (Parenthetical) HTML 42K 15: R4 Consolidated Statements of Operations HTML 83K 16: R5 Consolidated Statements of Comprehensive Income HTML 32K (Loss) 17: R6 Consolidated Statements of Changes in Equity HTML 85K 18: R7 Consolidated Statements of Changes in Equity HTML 21K (Parenthetical) 19: R8 Consolidated Statements of Cash Flows HTML 134K 20: R9 Basis of Presentation and Organization HTML 42K 21: R10 Accounts Receivable HTML 24K 22: R11 Acquisitions HTML 35K 23: R12 Fair Value Measurements HTML 121K 24: R13 Accrued Expenses and Other Current Liabilities HTML 45K 25: R14 Variable Interest Entities HTML 28K 26: R15 Noncontrolling Interests Subject to Put Provisions HTML 23K 27: R16 Debt HTML 75K 28: R17 Income Taxes HTML 23K 29: R18 Stock-Based Compensation HTML 73K 30: R19 Earnings Per Share HTML 103K 31: R20 Related Party Transactions HTML 35K 32: R21 Commitments and Contingencies HTML 29K 33: R22 Subsequent Events HTML 19K 34: R23 Basis of Presentation and Organization (Policies) HTML 44K 35: R24 Acquisitions (Tables) HTML 27K 36: R25 Fair Value Measurements (Tables) HTML 114K 37: R26 Accrued Expenses and Other Current Liabilities HTML 46K (Tables) 38: R27 Debt (Tables) HTML 62K 39: R28 Stock-Based Compensation (Tables) HTML 63K 40: R29 Earnings Per Share (Tables) HTML 100K 41: R30 Basis of Presentation and Organization (Details) HTML 74K 42: R31 Accounts Receivable (Details) HTML 27K 43: R32 Acquisitions (Details) HTML 31K 44: R33 Fair Value Measurements (Details) HTML 70K 45: R34 Accrued Expenses and Other Current Liabilities HTML 35K (Details) 46: R35 Variable Interest Entities Loans (Details) HTML 24K 47: R36 Noncontrolling Interests Subject to Put Provisions HTML 22K (Details) 48: R37 Debt (Details) HTML 59K 49: R38 Debt - Credit And Interest Rate Swap Agreements HTML 89K (Details) 50: R39 Income Taxes (Details) HTML 23K 51: R40 Stock-Based Compensation (Details) HTML 86K 52: R41 Earnings Per Share (Details) HTML 54K 53: R42 Related Party Transactions (Details) HTML 66K 54: R43 Commitments and Contingencies (Details) HTML 26K 55: R44 Subsequent Events (Details) HTML 19K 57: XML IDEA XML File -- Filing Summary XML 98K 56: EXCEL IDEA Workbook of Financial Reports XLSX 59K 6: EX-101.INS XBRL Instance -- c068-20160630 XML 1.15M 8: EX-101.CAL XBRL Calculations -- c068-20160630_cal XML 150K 9: EX-101.DEF XBRL Definitions -- c068-20160630_def XML 385K 10: EX-101.LAB XBRL Labels -- c068-20160630_lab XML 1.04M 11: EX-101.PRE XBRL Presentations -- c068-20160630_pre XML 715K 7: EX-101.SCH XBRL Schema -- c068-20160630 XSD 112K 58: ZIP XBRL Zipped Folder -- 0001498068-16-000011-xbrl Zip 119K
ara_Ex32-1 |
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of American Renal Associates Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph A. Carlucci, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
|
|
|
|
|
Chief Executive Officer |
Date: August 9, 2016
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.